Seguir
Bita Sahaf
Bita Sahaf
Research Scientist, PhD
Dirección de correo verificada de stanford.edu
Título
Citado por
Citado por
Año
The history and future of the fluorescence activated cell sorter and flow cytometry: a view from Stanford
LA Herzenberg, D Parks, B Sahaf, O Perez, M Roederer, LA Herzenberg
Clinical chemistry 48 (10), 1819-1827, 2002
7772002
Measurement and clinical monitoring of human lymphocyte clonality by massively parallel VDJ pyrosequencing
SD Boyd, EL Marshall, JD Merker, JM Maniar, LN Zhang, B Sahaf, ...
Science translational medicine 1 (12), 12ra23-12ra23, 2009
5322009
Individual variation in the germline Ig gene repertoire inferred from variable region gene rearrangements
SD Boyd, BA Gaëta, KJ Jackson, AZ Fire, EL Marshall, JD Merker, ...
The Journal of Immunology 184 (12), 6986-6992, 2010
3272010
Linkage of inflammation and oxidative stress via release of glutathionylated peroxiredoxin-2, which acts as a danger signal
S Salzano, P Checconi, EM Hanschmann, CH Lillig, LD Bowler, P Chan, ...
Proceedings of the National Academy of Sciences 111 (33), 12157-12162, 2014
3162014
Modern flow cytometry: a practical approach
JW Tung, K Heydari, R Tirouvanziam, B Sahaf, DR Parks, LA Herzenberg, ...
Clinics in laboratory medicine 27 (3), 453-468, 2007
2432007
High-throughput VDJ sequencing for quantification of minimal residual disease in chronic lymphocytic leukemia and immune reconstitution assessment
AC Logan, H Gao, C Wang, B Sahaf, CD Jones, EL Marshall, I Buño, ...
Proceedings of the National Academy of Sciences 108 (52), 21194-21199, 2011
2242011
Thioredoxin reductase, a redox-active selenoprotein, is secreted by normal and neoplastic cells: presence in human plasma
A Söderberg, B Sahaf, A Rosén
Cancer research 60 (8), 2281-2289, 2000
2152000
Lymphocyte surface thiol levels
B Sahaf, K Heydari, LA Herzenberg, LA Herzenberg
Proceedings of the National Academy of Sciences 100 (7), 4001-4005, 2003
1762003
CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial
JY Spiegel, S Patel, L Muffly, NM Hossain, J Oak, JH Baird, MJ Frank, ...
Nature medicine 27 (8), 1419-1431, 2021
1122021
Prophylactic rituximab after allogeneic transplantation decreases B-cell alloimmunity with low chronic GVHD incidence
S Arai, B Sahaf, B Narasimhan, GL Chen, CD Jones, R Lowsky, ...
Blood, The Journal of the American Society of Hematology 119 (25), 6145-6154, 2012
1102012
Thioredoxin expression and localization in human cell lines: detection of full-length and truncated species
B Sahaf, A Söderberg, G Spyrou, AM Barral, K Pekkari, A Holmgren, ...
Experimental cell research 236 (1), 181-192, 1997
921997
Ibrutinib efficacy and tolerability in patients with relapsed chronic lymphocytic leukemia following allogeneic HCT
CE Ryan, B Sahaf, AC Logan, S O’Brien, JC Byrd, P Hillmen, JR Brown, ...
Blood, The Journal of the American Society of Hematology 128 (25), 2899-2908, 2016
822016
The extracellular microenvironment plays a key role in regulating the redox status of cell surface proteins in HIV-infected subjects
B Sahaf, K Heydari, LA Herzenberg, LA Herzenberg
Archives of Biochemistry and Biophysics 434 (1), 26-32, 2005
822005
Comprehensive immune monitoring of clinical trials to advance human immunotherapy
FJ Hartmann, J Babdor, PF Gherardini, EAD Amir, K Jones, B Sahaf, ...
Cell reports 28 (3), 819-831. e4, 2019
752019
GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas
RG Majzner, S Ramakrishna, KW Yeom, S Patel, H Chinnasamy, ...
Nature 603 (7903), 934-941, 2022
722022
Clinical impact of HY alloimmunity
R Popli, B Sahaf, H Nakasone, JYY Lee, DB Miklos
Immunologic research 58 (2), 249-258, 2014
672014
Thioredoxin blood level increases after severe burn injury
A Abdiu, H Nakamura, B Sahaf, J Yodoi, A Holmgren, A Rosén
Antioxidants & redox signaling 2 (4), 707-716, 2000
662000
Allogeneic HY antibodies detected 3 months after female-to-male HCT predict chronic GVHD and nonrelapse mortality in humans
H Nakasone, L Tian, B Sahaf, T Kawase, K Schoenrock, S Perloff, ...
Blood, The Journal of the American Society of Hematology 125 (20), 3193-3201, 2015
592015
Phase I experience with a bi-specific CAR targeting CD19 and CD22 in adults with B-cell malignancies
N Hossain, B Sahaf, M Abramian, JY Spiegel, K Kong, S Kim, ...
Blood 132, 490, 2018
562018
Secretion of 10-kDa and 12-kDa thioredoxin species from blood monocytes and transformed leukocytes
B Sahaf, A Rosén
Antioxidants & redox signaling 2 (4), 717-726, 2000
552000
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20